Merger, Allocation of Purchase Price (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Nov. 05, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
||||
| Allocation of Purchase Price [Abstract] | ||||||
| Cash acquired | $ 2,014 | $ 2,014 | $ 0 | |||
| Net assets assumed | 68 | |||||
| IPR&D | 8,376 | [1] | $ 10,502 | $ 0 | ||
| Purchase price | $ 10,458 | |||||
| ||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of assets incurred by the acquirer as part of consideration transferred in a business combination. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. No definition available.
|